Board Appointment

Phytopharm PLC
21 July 2006


Company Contact:                                U.K. Investor Relations Contact:
Phytopharm plc                                  Financial Dynamics
Dr Richard Dixey                                David Yates / Ben Atwell
[phone]                                 [phone]
Dr Daryl Rees
[phone]
www.phytopharm.com


                                Board Appointment

GODMANCHESTER, Cambridgeshire, U.K. (July 21 2006) - Phytopharm plc (LSE: PYM;
NASDAQBB: PHYOF; PHYOY) ('Phytopharm') announces the appointment with immediate
effect of Dr Peter Robin Blower, former Director of New Neuroscience products at
SmithKline Beecham as a non-executive Board Director of Phytopharm.

Dr Blower (aged 58) has over 30 years experience in medicinal research and
development with a strong background in the field of neuroscience. Dr Blower
joined Beecham Research Laboratories in 1969 and rose to the position of
Director of New Neuroscience products in 1996 before leaving in 2000 to form his
own consultancy company. He has been elected to Fellowship of the Royal Society
of Medicine and the Institute of Biology and has authored over 50 scientific
publications. He has a M.I.Biol from the Institute of Biology (1972), a PhD in
Pharmacology from the University of Aston (1977) and a DSc from the University
of East London (1997).

Commenting on the appointment, Mr Gordon Stevens, Chairman of Phytopharm, said;
'This appointment adds further relevant experience and strength to our Board,
particularly in the field of neurology.  This follows the recent appointment of
Sandy Morrison, former CEO of Lipton Ltd, a Unilever subsidiary. I am delighted
that Peter is joining us and look forward to confirming further Board
developments in due course.'

Dr Blower is currently a director of Biophar Consulting Ltd and Minster
Pharmaceuticals plc. There are no further details required to be disclosed under
paragraph 9.6.13R of the Listing Rules or Disclosure Rule 3.1.2R.



                                     -ENDS-

NOTES TO EDITORS

Phytopharm plc

Phytopharm is a pharmaceutical company with a plant extract division. The
pharmaceutical division is dedicated to the discovery and development of single
chemicals as prescription medicines and the plant extract division is focussed
on the development of plant extracts as functional foods and veterinary
products.



More information concerning Phytopharm's activities can be found on its website
                          at http://www.phytopharm.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange